A lactic acid bacterium found in the human small intestine and in fermented dairy, and the species most people picture when they hear the word probiotic. Commercial products use many different strains under this species name.
Acidophilus is the clearest case of a species trading on a reputation that belongs, at best, to a few of its members. Some strains have been studied properly — NCFM has trials in lactose digestion and abdominal symptoms, and La-5 appears in blend research — but a supplement labelled only "Lactobacillus acidophilus" is not identifying which organism is inside, and there is no basis for transferring a trial result to it. The most defensible use is the oldest one: strains that produce beta-galactosidase help people with lactose intolerance digest lactose, which is a well-characterised enzymatic effect rather than a microbiome claim.
CFU per dose; the strain designation is the number that actually matters and is often absent — a product without this marker may not resemble what was studied.
Also known as
L. acidophilus, Acidophilus, NCFM strain
Regulation: Sold as a dietary supplement with no pre-market efficacy review. EFSA has not authorised general probiotic claims in the EU. Because there is no requirement to identify the strain on a label, two products with identical species names may contain entirely different organisms.
What the research used
The amounts, forms and durations published trials of Lactobacillus acidophilus actually administered.
These are the amounts published trials administered — not a recommendation, and not a dose to copy. Trial participants were screened, supervised and given a characterised preparation. What is in a retail bottle is frequently not what was studied, and the amount that suits one person is not general advice.
Studied for Digestive symptoms and lactose digestion
1–10 billion CFU
Limited
Capsule or fermented milk, daily · 2–8 weeks
The range across trials of various strains. Because the strain is usually unnamed on retail products, matching a dose to a trial is generally not possible.
This is general information about food, not medical advice. It cannot diagnose, treat or replace guidance from a clinician who knows your history.
When it was taken
Each window says whether a trial compared it against an alternative, or whether it is convention and pharmacology. Most timing advice is the second kind.
Each timing below was actually compared against an alternative in a trial, which is unusual.
🍽️With food
Limited
Gastric survival improves when taken with a meal containing fat or with milk, and this has been directly measured for several lactobacilli. Acidophilus is less acid-tolerant than some spore formers, so this matters more here than for a Bacillus product.
Timing was tested. A trial compared this window against another and reported a difference.
The evidence in depth
Best supported: Limited
What each association actually rests on, and the papers behind it. A rating describes the state of the research, not how promising the supplement sounds. How we rate evidence.
Some strains labelled L. acidophilus have been studied for bloating and abdominal discomfort with modest reported benefits, but the trials are small, the strains differ and retail products rarely identify which organism they contain.
Limited evidence. Early human work, or mostly lab and animal research.
Trials of acidophilus-containing products on glucose and insulin markers report inconsistent results, usually as part of multi-strain blends where the contribution of any one organism cannot be separated.
Not enough evidence. Not enough human research to say anything useful yet.
There is not enough strain-identified human research to say Lactobacillus acidophilus affects infection rates. Most supporting material comes from blends, laboratory immune markers or other species entirely.
Not enough evidence. Not enough human research to say anything useful yet.
Deep research mode adds each paper’s own conclusion and stated limitations.
Things to know
Interactions, contraindications and dose limits, most serious first. Concentrated extracts interact with medication in ways the whole plant does not, so this section carries more weight here than it does on a food page.
Avoid
Immunocompromise and critical illness
Lactobacillus bacteraemia and endocarditis have been documented in immunocompromised patients, in people with central venous catheters and after cardiac valve surgery. Live cultures should not be started by critically ill or severely immunosuppressed people without specialist advice.
Worth knowing
Unnamed strains cannot inherit trial evidence
A label that says only "Lactobacillus acidophilus" identifies a species, not the organism that was studied. Any claim attached to such a product is borrowed from research on a different bacterium.
Allergy
Dairy and other carrier ingredients
Many acidophilus products are grown on or carried in milk-derived media and may contain traces of dairy protein, which matters for milk allergy rather than for lactose intolerance.
Too much
Transient gas and bloating
The usual first-week effects, which normally settle. Persistent worsening is a reason to stop rather than to increase the dose.
In the food catalogue
The whole-food form, where one exists. The evidence for a concentrated extract rarely transfers to the food, or the other way round — these are cross-links, not equivalents.